ATC level 3
L02BHormonal cancer treatments, subgroup L02B
- Molecules
- 18
- Subgroups
- 4
ATC L02B (Hormonal cancer treatments, subgroup L02B) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 18 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under L02B.
- AbirateroneCytochrome P450 17A1 Inhibitor7 presentations7 brandsL02BX03
- AnastrozoleAromatase Inhibitor2 presentations1 brandL02BG03
- Apalutamide2 presentations2 brandsL02BB05
- BicalutamideAndrogen Receptor Inhibitor2 presentations1 brandL02BB03
- Camizestrant1 presentation2 brandsL02BA05
- Darolutamide1 presentation2 brandsL02BB
- Degarelix1 presentation3 brandsL02BX02
- ElacestrantEstrogen Receptor Antagonist2 presentations1 brandL02BA
- EnzalutamideAndrogen Receptor Inhibitor3 presentations4 brandsL02BB04
- ExemestaneOrphanAromatase Inhibitor2 presentations1 brandL02BG06
- FlutamideAndrogen Receptor Inhibitor1 presentation1 brandL02BB01
- FulvestrantEstrogen Receptor Antagonist4 presentations4 brandsL02BA03
- ImlunestrantEstrogen Receptor Antagonist1 presentation2 brandsL02BA
- LetrozoleAromatase Inhibitor2 presentations1 brandL02BG04
- NilutamideAndrogen Receptor Inhibitor1 presentationL02BB02
- RelugolixGonadotropin Releasing Hormone Receptor Antagonist1 presentation2 brandsL02BX
- TamoxifenEstrogen Agonist/Antagonist3 presentations1 brandL02BA01
- ToremifeneOrphanEstrogen Agonist/Antagonist2 presentations2 brandsL02BA02
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.